[HTML][HTML] Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations
Cerebral microbleeds (microbleeds) are small, punctuate hypointense lesions seen in T2*
Gradient-Recall Echo (GRE) and Susceptibility-Weighted (SWI) Magnetic Resonance …
Gradient-Recall Echo (GRE) and Susceptibility-Weighted (SWI) Magnetic Resonance …
Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study
MMF Poels, MA Ikram, A van der Lugt, A Hofman… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—Cerebral microbleeds are frequently seen in the general elderly
population, but it is unknown at what rate they occur with aging and whether once present …
population, but it is unknown at what rate they occur with aging and whether once present …
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study
Background and Purpose—Cerebral microbleeds (CMBs) are areas of low signal intensity
on gradient echo T2*-weighted magnetic resonance imaging (T2* MRI) corresponding to …
on gradient echo T2*-weighted magnetic resonance imaging (T2* MRI) corresponding to …
Cerebral microbleeds: old leaks and new haemorrhages
J Fiehler - International Journal of Stroke, 2006 - journals.sagepub.com
Black dots in the brain parenchyma diagnosed in T2*-weighted magnetic resonance
imaging should be interpreted in light of the patient's history as well as the location, number …
imaging should be interpreted in light of the patient's history as well as the location, number …
Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study
MMF Poels, MW Vernooij, MA Ikram, A Hofman… - Stroke, 2010 - Am Heart Assoc
Background and Purpose—We previously reported on the high prevalence of cerebral
microbleeds (CMBs) in community-dwelling people aged 60 years and older. Moreover, we …
microbleeds (CMBs) in community-dwelling people aged 60 years and older. Moreover, we …
The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods
A Charidimou, D Wilson, C Shakeshaft… - … Journal of Stroke, 2015 - journals.sagepub.com
Background and rationale The increasing use of oral anticoagulants, mostly to prevent
ischemic stroke due to atrial fibrillation in an ageing population, has been associated with a …
ischemic stroke due to atrial fibrillation in an ageing population, has been associated with a …
Genetic associations with brain microbleeds: systematic review and meta-analyses
SS Maxwell, CA Jackson, L Paternoster, C Cordonnier… - Neurology, 2011 - AAN Enterprises
Objective: We performed a systematic review and meta-analyses to assess the evidence for
genetic associations with brain microbleeds (BMBs). Methods: We sought all published …
genetic associations with brain microbleeds (BMBs). Methods: We sought all published …
Incidence of symptomatic hemorrhage in patients with lobar microbleeds
ES van Etten, E Auriel, KE Haley, AM Ayres… - Stroke, 2014 - Am Heart Assoc
Background and Purpose—Lobar microbleeds suggestive of cerebral amyloid angiopathy
(CAA) are often identified on MRI in the absence of lobar intracerebral hemorrhage (ICH) …
(CAA) are often identified on MRI in the absence of lobar intracerebral hemorrhage (ICH) …
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study
MW Vernooij, A van der Lugt, MA Ikram… - Neurology, 2008 - AAN Enterprises
Background: Cerebral microbleeds are focal deposits of hemosiderin that can be visualized
with MRI. Little is known on their prevalence in the general population and on their etiology …
with MRI. Little is known on their prevalence in the general population and on their etiology …
Cerebral microbleeds: is antithrombotic therapy safe to administer?
Z Wang, YOY Soo, VCT Mok - Stroke, 2014 - Am Heart Assoc
Few studies investigated the frequency of CMBs in patients with myocardial infarction or
peripheral arterial diseases, which are other common indications for antithrombotic therapy …
peripheral arterial diseases, which are other common indications for antithrombotic therapy …